ArticleDiagnostics (Basel, Switzerland)2022
COVID-19 Infection Segmentation and Severity Assessment Using a Self-Supervised Learning Approach.
Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 13 citations in OpenAlex.
- Explainable self-supervised learning for medical image diagnosis based on DINO V2 model and semantic search.Scientific reports · 2025Article
- A Novel Deep Learning-Based Classification Framework for COVID-19 Assisted with Weighted Average Ensemble Modeling.Diagnostics (Basel, Switzerland) · 2023Article
- Analysis of Chest X-ray for COVID-19 Diagnosis as a Use Case for an HPC-Enabled Data Analysis and Machine Learning Platform for Medical Diagnosis Support.Diagnostics (Basel, Switzerland) · 2023Article
- Multi-Stage Temporal Convolutional Network with Moment Loss and Positional Encoding for Surgical Phase Recognition.Diagnostics (Basel, Switzerland) · 2022Article
- COVID-19 Inflammatory Markers and Vitamin D Relationship in Pediatric Patients.Life (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAutomated segmentation of COVID-19 infection lesions and the assessment of the severity of the infections are critical in COVID-19 diagnosis and treatment. Based on a large amount of annotated data, deep learning approaches have been widely used in COVID-19 medical image analysis. However, the number of medical image samples is generally huge, and it is challenging to obtain enough annotated medical images for training a deep CNN model.
methodsTo address these challenges, we propose a novel self-supervised deep learning method for automated segmentation of COVID-19 infection lesions and assessing the severity of infection, which can reduce the dependence on the annotation of the training samples. In the proposed method, first, many unlabeled data are used to pre-train an encoder-decoder model to learn rotation-dependent and rotation-invariant features. Then, a small amount of labeled data is used to fine-tune the pre-trained encoder-decoder for COVID-19 severity classification and lesion segmentation.
resultsThe proposed methods were tested on two public COVID-19 CT datasets and one self-built dataset. Accuracy, precision, recall, and F1-score were used to measure classification performance and Dice coefficient was used to measure segmentation performance. For COVID-19 severity classification, the proposed method outperformed other unsupervised feature learning methods by about 7.16% in accuracy. For segmentation, when the amount of labeled data was 100%, the Dice value of the proposed method was 5.58% higher than that of U-Net.; in 70% of the cases, our method was 8.02% higher than U-Net; in 30% of the cases, our method was 11.88% higher than U-Net; and in 10% of the cases, our method was 16.88% higher than U-Net.
conclusionsThe proposed method provides better classification and segmentation performance under limited labeled data than other methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.